Company news
Braxia Scientific Corp (CSE:BRAX) news
Braxia Scientific Corp news releases on 6ix. Latest, Feb 19, 2025: Braxia Scientific Update
Press releases & updates
Braxia Scientific Update
February 19, 2025
Braxia Scientific Announces Change in Directors and CEO
November 18, 2024
Braxia Scientific Announces Voting Results from the Annual General and Special Meeting of Shareholders
October 10, 2024
Braxia Announces Annual General and Special Meeting
September 10, 2024
Braxia Scientific Announces Cease Trade Order
August 5, 2024
Braxia Scientific Provides Update on Application for Management Cease Trade Order
July 25, 2024
Braxia Scientific Announces Application for a Management Cease Trade Order For Late Filing of Audited Annual Financial Statements
July 15, 2024
Braxia Scientific Reports Q3 2024 Financial Results
February 29, 2024
Braxia Scientific Reports Mandatory Conversion of Debentures
January 15, 2024
Braxia Scientific Reports Q2 2024 Financial Results and Provides Corporate Update
November 30, 2023
Braxia Scientific Reports Q1 Fiscal 2024 Financial Results
August 30, 2023
Braxia Scientific Reports Fiscal 2023 Financial Results
July 30, 2023
RETRANSMISSION: Braxia Scientific Reports a 26% Increase in Total Treatment Volumes in F2023 and an 87% Increase in Treatments at Newly Expanded Ottawa Clinic
June 12, 2023
Braxia Scientific Reports a 26% Increase in Total Treatment Volumes in F2023 and an 87% Increase in Treatments at Newly Expanded Ottawa Clinic
June 9, 2023
Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine and Psychedelics Clinical IP
March 16, 2023
Braxia Scientific Reports Q3 2023 Financial Results and Provides Update on Acquisition Under LOI with Irwin Naturals
February 28, 2023
Braxia Scientific Announces Closing of First Tranche of LIFE Offering and Concurrent Private Placement
February 26, 2023
Braxia Scientific signs non-binding letter of intent to sell company to Irwin Naturals
February 7, 2023
Braxia Scientific Announces Offering up to $1.5 Million, Braxia Management to Participate in Concurrent Private Placement
February 7, 2023
RETRANSMISSION: Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific
January 30, 2023
Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific
January 27, 2023
Irwin Naturals and Braxia Scientific Sign Letter of Intent Entering Partnership to Launch In-Human Clinical Studies to Support Pharmaceutical Sponsors Across U.S.
January 10, 2023
Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic and Telemedicine Delivery of Novel Mental Health Treatments in North America
November 29, 2022
Braxia Scientific Announces Board Appointment
September 21, 2022
Braxia Scientific Reports Q1 2023 Financial Results, Launches KetaMD in U.S. Increasing Treatment Access for Mental Health Patients
August 30, 2022
Braxia Scientific Enters U.S. Telemedicine Industry, Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with plans to expand across the U.S.
August 4, 2022